The authors report a case of unequivocal Neuroleptic Malignant Syndrome, in which the patient was successfully rechallenged with a different potent neuroleptic in substantial dosage during the recovery phase. The Neuroleptic Malignant Syndrome did not recur and the patient's psychosis cleared. Reference is made to the relevant world literature.
LevisonD.F., SimpsonG.M.Neuroleptic-induced extrapyramidal symptoms with fever: heterogeneity of the neuroleptic malignant syndrome.Arch Gen Psychiatry1986; 53: 839–848.
8.
LazarusA.The neuroleptic malignant syndrome: a review.Can J Psychiatry1986; 31(7): 670–673.
KellamA.M.P.The neuroleptic malignant syndrome, so-called: a survey of the world literature.Br J Psychiatry1987; 150: 752–759.
12.
HarschH.H.Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.J Clin Psychiatry1987; 48: 328–333.
13.
PopeH.G., KeckP.E., McElroyS.L.Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.Am J Psychiatry1986; 143: 1227–1233.
14.
AddonizioG., SusmanV.L., RothS.D.Symptoms of neuroleptic malignant syndrome in 82 consecutive in-patients.Am J Psychiatry1986; 143: 1587–1590.
MeltzerH.Y.Rigidity, hyperpyrexia and coma following fluphenazine enanthate.Psychopharmacologia1987; 29: 337–346.
20.
BernsteinR.A.Malignant neuroleptic syndrome: an atypical case.Psychosomatics1979; 20: 840–846.
21.
BurkeR.E., FahnS., MayeuxR.Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.Neurology1981; 31: 1022–1026.
